Edan Debuts Next-Gen Blood Gas & Chemistry Analyzer and Patient Monitor at MEDICA 2021

By HospiMedica International staff writers
Posted on 17 Nov 2021

Image: EDAN at MEDICA 2021 (Photo courtesy of EDAN Instruments, Inc.)

EDAN Instruments, Inc. (Shenzhen, China) introduced five new products that are aimed at improving caregiver efficacy and resource accessibility at MEDICA 2021.

Three ready-to-launch products from EDAN, namely its next-gen blood gas and chemistry analysis system i20, 3rd Generation patient monitor iX Series, and the integrated portable version biofeedback and stimulation system PA4 Pro made their debut at MEDICA 2021. EDAN also highlighted its recently-introduced paperless tablet ECG machine iSE and 5-part auto hematology analyzer H60s.

EDAN’s iSE series 12/18 lead ECG machine features an outstanding tablet design and is intended to bring exceptional mobile experience and build a seamless connection to IT systems. It is suitable for applications such as ambulance or first-aid, as well as modern paperless informationized hospitals. Weighing less than one kg, it can start sampling automatically once all lead cables are connected and the desired signal quality is achieved. Its innovative self-adaptive AC filter technology ensures more desirable ECG signal quality in real clinical settings, especially under extreme environments with unstable voltage.

"The products we present this time is mind-changing," said EDAN's Senior Director of Global Marketing and Strategic Operations, Alex You. "In healthcare, efficacy speaks volumes about how technologies make a positive impact on paramedics' workflow, and further save time for patient interaction and more. On iSE, you can have a glance at our plan in IoMT. Intelligent healthcare and IoT-enabled devices have been our focus in recent years. We believe med-tech can improve patient care, and IoT can make this one step further."

"EDAN remains committed to improving people's lives by providing value-driven, user-centered products. The needs are continually evolving. And that's our job to adapt to it and continually optimize our products for the market," added Hao Zhang, CEO of EDAN. "Our mission is to make caregivers' work easier so that they could do more for patients. And the product we present this time just speaks for it."

Related Links:
EDAN Instruments, Inc.

Visit expo >

Gold Member

Neonatal Heel Incision Device

Tenderfoot

Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel

Hypodermic Syringe

SurTract™ Safety Syringe

Surgical Dressing

ALLEVYN Ag+ SURGICAL

Latest Medica 2021 News

Channels

Artificial Intelligence

view channel

Image: Neuvotion is developing AI-guided brain-body interface (BBI) technologies, defining a new category in medicine and revolutionizing neurorecovery. (Photo courtesy of Neuvotion)

Critical Care

view channel

FDA-Cleared Index Enables Pediatric-Specific Sedation Monitoring

Achieving appropriate depth of sedation in children is a persistent challenge because pediatric brains respond differently to anesthetic drugs than adult brains. In perioperative and intensive care settings,... Read more

Smart Ring Continuously Monitors Glucose and Ketones from Passive Sweat

Most consumer wearables report biophysical metrics and do not capture molecular data from the body. This gap limits continuous insight into biomarkers used to guide health management, including glucose... Read more

Invisible Skin Sensors Could Transform Everyday Biosignal Monitoring

Wearable sensors for facial biosignals are often bulky, conspicuous, and uncomfortable. Their visibility can introduce “appearance artifacts,” in which behavior and psychological state change simply because... Read more

Image: Graphical Abstract (Zhao YC, Liu Y, Wang Z, et al. Cell Biomaterials (2026). DOI: 10.1016/j.celbio.2026.100541)

Patient-Specific Artery-on-a-Chip Refines Stroke Risk Stratification

Predicting which patients will experience an ischemic stroke remains challenging because clot detachment and travel differ widely among individuals. Risk assessment often centers on arterial narrowing,... Read more

Surgical Techniques

view channel

Image: The AI system analyzes surgical technique during prostate cancer surgery to identify movements associated with better patient outcomes (Image Credit: Shutterstock)

AI Analyzes Surgical Movements to Improve Prostatectomy Outcomes

Nerve-sparing prostatectomy seeks to remove cancer while preserving neurovascular bundles that enable sexual function, yet outcomes vary widely. Assessing how specific intraoperative movements affect recovery... Read more

Image: Chemical structure of the newly developed near-infrared polymer (KR-NIR-P) and its enhanced photostability. (Photo courtesy of Korea Research Institute of Chemical Technology)

Photostable NIR Dye Sustains Intraoperative Imaging in Cancer Surgery

Near-infrared (NIR) fluorescence is widely used to guide oncologic resections and lymphatic mapping, yet signal fading during continuous illumination can compromise accuracy in long operations.... Read more

Next-Generation Total Artificial Heart System to Be Presented at IEEE EMBC 2026

End-stage heart failure remains a major driver of morbidity and mortality, and some patients continue to decline while awaiting heart transplantation. When conventional mechanical circulatory support is... Read more

$Image: The Momentis Surgical Anovo® Surgical System, a flexible robotic surgery platform designed to support natural orifice, single-port, and multiport minimally invasive procedures. The FDA has cleared the system\'s multiport configuration, making it the first robotic platform capable of supporting all three surgical access approaches on a single system (Photo courtesy of Momentis Surgical)$